Late Breaking Abstract - ENose based phenotyping of newly presented patients with asthma or COPD

R. de Vries (Amsterdam, Netherlands), Y. Dagelet (Amsterdam, Netherlands), S. Kester (Den Bosch, Netherlands), J. In 'T Veen (Rotterdam, Netherlands), E. Haarman (Amsterdam, Netherlands), A. Lucas (Eindhoven, Netherlands), F. De Jongh (Enschede, Netherlands), A. Maitland-Van Der Zee (Amsterdam, Netherlands), P. Sterk (Amsterdam, Netherlands)

Source: International Congress 2018 – Biomarkers in COPD and asthma
Session: Biomarkers in COPD and asthma
Session type: Oral Presentation
Number: 3577
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. de Vries (Amsterdam, Netherlands), Y. Dagelet (Amsterdam, Netherlands), S. Kester (Den Bosch, Netherlands), J. In 'T Veen (Rotterdam, Netherlands), E. Haarman (Amsterdam, Netherlands), A. Lucas (Eindhoven, Netherlands), F. De Jongh (Enschede, Netherlands), A. Maitland-Van Der Zee (Amsterdam, Netherlands), P. Sterk (Amsterdam, Netherlands). Late Breaking Abstract - ENose based phenotyping of newly presented patients with asthma or COPD. 3577

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Late Breaking Abstract - Detection of clinical instability by eNose in COPD patients
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018




Late Breaking Abstract - Relationship between clinical features and mortality in a cohort of COPD patients.
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021


Late Breaking Abstract - Determinants of disease control in patients with severe COPD. The CLAVE Study
Source: International Congress 2019 – Clinical approach to asthma management
Year: 2019


Late Breaking Abstract - Adherence to GOLD recommendations in Italian patients with COPD categorised as frequent and non-frequent exacerbators: The MISTRAL study
Source: International Congress 2017 – Late-breaking findings in asthma and COPD
Year: 2017


Late Breaking Abstract - Effect of inhaled corticosteroids on exacerbation of asthma–COPD overlap according to different diagnostic criteria
Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more
Year: 2019


Late Breaking Abstract - Cluster analysis of treatable traits in the U-BIOPRED adult severe asthma cohort
Source: International Congress 2017 – Asthma and ACOS: predictors and clinical characteristics
Year: 2017



Late Breaking Abstract - Characterizing responders to benralizumab for severe asthma: pooled analysis of the SIROCCO and CALIMA studies
Source: International Congress 2017 – Update and new perspectives in Airway Diseases
Year: 2017



Late Breaking Abstract - Longitudinal analysis of variation in clinical features from the U-BIOPRED severe asthma cohort
Source: International Congress 2018 – Notable Studies in Asthma
Year: 2018



Late Breaking Abstract - Identification of patients with COPD who benefit from benralizumab
Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: COPD and cough
Year: 2019



Late Breaking Abstract - International, prospective real-world study of mepolizumab in patients with severe asthma at one year: REALITI-A
Source: Virtual Congress 2021 – Advances in asthma treatment
Year: 2021


Late Breaking Abstract - Comparison of clinical characteristics between severe adult asthmatics in Brazil(ProAR) and Europe(U-BIOPRED).
Source: International Congress 2017 – Late-breaking findings in asthma and COPD
Year: 2017

Late Breaking Abstract - Real-world evidence of dual bronchodilator therapy using Clinical COPD Questionnaire in 4700 COPD patients
Source: Virtual Congress 2020 – Advances in pharmacological treatment of COPD
Year: 2020




Late Breaking Abstract - Defining a severe asthma super-responder: findings from a Delphi process
Source: Virtual Congress 2020 – Advances in asthma treatment
Year: 2020


Late Breaking Abstract - Tiotropium/olodaterol improves pulmonary function in patients with treatment naive COPD
Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies
Year: 2019


Late Breaking Abstract - Diagnosis of chronic obstructive pulmonary disease (COPD) exacerbations using a smartphone-based, cough-centred algorithm
Source: International Congress 2019 – Research and innovation in airway diseases
Year: 2019


Late Breaking Abstract - Recurrent Neural Networks and environmental data for COPD exacerbation prediction
Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases
Year: 2020


Late Breaking Abstract - Shared genetic origins of obesity and poor ICS response in children with asthma
Source: Virtual Congress 2021 – Lung disease burden and management
Year: 2021


Late Breaking Abstract - HRQol and other health related variables of Spanish COPD patients
Source: Virtual Congress 2020 – Interesting clinical problems for the respiratory physician
Year: 2020


Late Breaking Abstract - Validation of a tool for the assessment of disease awareness (DA) in COPD
Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer
Year: 2017


Late Breaking Abstract - European prevalence of OSA in adults: Estimation using currently available data
Source: International Congress 2018 – Epidemiology, phenotypes and cardiometabolic comorbidities of obstructive sleep apnoea
Year: 2018